Effects of selective phosphodiesterase 3 inhibition in the perfused liver of the rat after endotoxin treatment

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 790-796

  Weidenbach, H ^a   Beckh, K ^a   Burger, M ^a   Schricker, T ^b   Georgieff, M ^b   Adler, G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Clinic for Anesthesiology   (Germany)

Author keywords

Bile flow; Carbohydrate metabolism; Cyclic AMP; Cyclic AMP phosphodiesterase 3; Endotoxin; Enoximone; Liver

Indexed keywords

CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; ENDOTOXIN; ENOXIMONE; GLUCAGON; GLUCOSE; LACTIC ACID; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE TRANSPORT; LIVER METABOLISM; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEPSIS; SYMPATHETIC NERVE;

EID: 0029952510     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15469.x     Document Type: Article

References (36)

1. BAGDADE, J., ROOT, R. & BULGER, R. (1971). Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes, 23, 9-15.
2. BECKH, K. & ARNOLD, R. (1991). Regulation of bile secretion by sympathetic nerves in perfused rat liver. Am. J. Physiol., 261, G775-G780.
3. BECKH, K., KNEIP, S. & ARNOLD, R. (1994). Direct regulation of bile secretion by prostaglandins in perfused rat liver. Hepatology, 19, 1208-1213.
4. BERGMEYER, H.U. (1994). Methods of Enzymatic Analysis. 3rd. ed. New York and London: Academic Press, Inc.
5. BRONSTAD, G.O. & CHRISTOFFERSEN, T. (1981). Inhibitory effect of prostaglandins on the stimulation by glucagon and adrenaline of formation of cyclic AMP in rat hepatocytes. Eur. J. Biochem., 117, 369-374.
6. CASTELIJN, E., KUIPERS, J., VAN ROOIJ, H.C.J., KAMPS, J.A.A.M., FOSTER, J.F. & VAN BERKEL, T.J.C. (1988). Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J. Biol. Chem., 263, 6953-6955.
7. CEPPI, E.D., KNOWLES, R.G. CARPENTER, K.M. & TITHERADGE, M.A. (1992). Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cell. Biochem. J., 284, 761-766.
8. COLUCCI, W.S., WRIGHT, R.F. & BRAUNWALD, E. (1986). New positive inotropic agents in the treatment of congestive heart failure. N. Engl. J. Med., 314, 290-349.
9. ECKLY, A.E. & LUGNIER, C. (1994). Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol., 113, 445-450.
10. FILKINS, J.P. & CORNELL, R. (1974). Depression of hepatic gluconeogenesis and the hypoglycaemia of endotoxin shock. Am. J. Physiol., 227, 778-781.
11. GROUS, M. & BARNETTE, M. (1994). Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonie smooth muscle. Br. J. Pharmacol., 111, 259-263.
12. 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology, 20, 638-642.
13. KAUFFMAN, R.F., SCHENCK, K.W., UTTERBACK, B.G., CROWE, V.G. & COHEN, M.L. (1987). In vitro vascular relaxation by new inotropic agents. Relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther., 242, 864-872.
14. KOGA, S., MORRIS, S., OGAWA, S., LIAO, H., BILEZIKIAN, J.P., CHEN, G., THOMPSON, W.J., ASHIKAGA, T., BRETT, J., STERN, D.M. & PINSKY, D.J. (1995). TNF modulates endothelial properties by decreasing cAMP. Am. J. Physiol., 268, C1104-1113.
15. LENZEN, R., HRUBY, V.J. & TAVOLONI, N. (1990). Mechanism of glucagon cholercsis in guinea pigs. Am. J. Physiol., 259, G736-G744.
16. LIU, M.S. & GHOSH, S. (1983). Changes in β-adrenergic receptors in dog liver during endotoxin shock. Am. J. Physiol., 244, R718-R723.
17. LONGSTRETH, W.T. & INUT, T.S. (1985). High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann. Surg., 198, 59-63.
18. LUGNIER, C., SCHOEFFTER, P., LEBEC, A., STROUTHOU, E. & STOCLET, J.C. (1986). Selective inhibition of cyclic nucleotide phosphodiesterase of human, bovine and rat aorta. Biochem. Pharmacol., 35, 1743-1751.
19. LUSTER, M.I., GERMOLEC, D.R., YOSHIDA, T., KAYAMA, F. & THOMPSON, M. (1994). Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology, 19, 480-488.
20. McCLUSKEY, R.S. (1993). Hepatic microvascular responses to endotoxinemia and sepsis. Prog. Appl. Microcirc., 19, 76-84.
21. OKADA, F., NAGAO, S., HARADA, Y., XAVIER, R.M., NAKAMURA, M., ISHIDA, T. & TANIGAWA, Y. (1995). The role of cyclic AMP in the lipopolysaccharide-induced suppression of thymidine kinase activity in macrophage. Biochim. Biophys. Acta, 1265, 201-208.
22. PARKER, M.M. & PARRILLO, J.E. (1983). Septic shock. Hemodynamics and pathogenesis. J. Am. Med. Assoc., 250, 3324-3327.
23. PYNE, N.J., COOPER, M.E. & HOUSLAY, M.D. (1987). The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Biochem. J., 242, 33-42.
24. RAETZ, C.R.H., ULEVITCH, R.J., WRIGHT, S.D., SIBLEY, C.H., DING, A. & NATHAN, C.F. (1991). Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB. J., 5, 2652-2660.
25. SHANGRAW, R.E., JAHOOR, F., MIYOSHI, H., NEFF, W.A., STUART, C.A., HERNDON, D.N. & WOLFE, R.R. (1989). Differentiation between septic and postburn insulin resistance. Metabolism, 38, 983-989.
26. m) cyclic adenosine monophosphate phosphodiesterase. Am. J. Cardiol., 63, 2A-8A.
27. TOMIHIRO, H., BRUCK, R., CHENG, N.O. & BOYER, J.L. (1990). DBG cAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am. J. Physiol., 259, G727-G735.
28. TURLEY, S.D. & DIETSCHY, J.M. (1978). Re-evaluation of the 3-alpha-hydroxy-steroid dehydrogenase assay for total bile acids in bile. J. Lipid Res., 19, 924-928.
29. UTILI, R., ABERNATHY, C.O. & ZIMMERMAN, H.G. (1976). Cholestatic effects of escherichia coli endotoxin on the isolated perfused rat liver. Gastroenterologe, 70, 248-253.
30. VAN SCHAFTINGEN, E. (1990). Role of fructose 2,6-bisphosphate in the regulation of hepatic carbohydrate metabolism. In Fructose-2,6-hisphosphated. Pilkis S.J. pp. 65-85. Boca Raton: CRC Press.
31. VERGHESE, M.W, MCCONNELL, R.T., LENHARD, J.M., HAMACHER, L. & JIN, S.L. (1995). Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol., 47, 1164-1171.
32. VINCENT, J.L., DOMB, M. & VAN DER LINDEN, P. (1988). Amrinone administration in endotoxic shock. Circ. Shock, 25, 75.
33. 2α in the perfused rat liver. Biochim. Biophys. Acta, 1245, 181-186.
34. WEIDENBACH, H., BECKH, K., SCHRICKER, T., GEORGIEFF, M. & ADLER, G. (1995b). Enhancement of hepatic glucose release and bile flow by the phosphodiesterase III inhibitor enoximone in the perfused rat liver. Life Sci., 56, 20, 1721-1726.
35. WETTSTEIN, M., GEROK, W. & HÄUSSINGER, D. (1994). Endotoxin-induced nitric oxide synthesis in the perfused rat liver: Effects of L-Arginine and ammonium chloride. Hepatology, 19, 641-647.
36. YOUSSEF, J., ABDEL-ALEEM, S. & BADR, M. (1994). Enoximone inhibits hepatic mitochondrial long-chain acyl-CoA synthetase. Toxicol-Lett., 74, 15-21.